GABLES CAPITAL MANAGEMENT INC. - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
GABLES CAPITAL MANAGEMENT INC. ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,049,554
-13.6%
431,955
-0.7%
3.51%
-8.2%
Q2 2023$5,845,459
-13.8%
434,930
+6.3%
3.83%
-19.2%
Q1 2023$6,782,546
-13.7%
409,080
-3.2%
4.74%
-17.2%
Q4 2022$7,860,453
+41.2%
422,605
-2.6%
5.72%
+28.1%
Q3 2022$5,566,000
+82.2%
433,814
-0.4%
4.46%
+93.5%
Q2 2022$3,055,000
-16.0%
435,764
-0.7%
2.31%
+1.1%
Q1 2022$3,637,000
+19.6%
438,764
-2.3%
2.28%
+26.0%
Q4 2021$3,041,000
+46.6%
449,164
+14.7%
1.81%
+33.8%
Q3 2021$2,075,000
+5.5%
391,564
+14.5%
1.35%
+0.6%
Q2 2021$1,966,000
+4.7%
341,964
-16.0%
1.35%
+30.9%
Q1 2021$1,877,000
+35.9%
407,064
-1.5%
1.03%
+27.5%
Q4 2020$1,381,000
+7.4%
413,364
-4.5%
0.81%
-2.9%
Q3 2020$1,286,000
-45.1%
432,864
-14.6%
0.83%
-48.9%
Q2 2020$2,342,000
+18.3%
506,864
-1.2%
1.62%
-0.2%
Q1 2020$1,979,000
+1.8%
512,864
-1.0%
1.63%
+24.8%
Q4 2019$1,944,000
-25.4%
517,864
+5.6%
1.30%
-29.3%
Q3 2019$2,606,000
+39.4%
490,564
+0.9%
1.84%
+20.9%
Q2 2019$1,869,000
-23.7%
486,064
+1.3%
1.52%
-22.6%
Q1 2019$2,449,000
+165.3%
479,764
-0.2%
1.97%
+145.0%
Q4 2018$923,000
-45.5%
480,764
+7.3%
0.80%
-37.7%
Q3 2018$1,694,000
+12.5%
448,264
+0.7%
1.29%
+5.1%
Q2 2018$1,506,000
+37.3%
445,264
-3.0%
1.23%
+26.5%
Q1 2018$1,097,000458,8640.97%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders